180 DEGREE CAPITAL CORP. |
(Exact Name of Registrant as Specified in Its Charter) |
7 N. Willow Street, Suite 4B, Montclair NJ | 07042 | |
(Address of Principal Executive Offices) | (Zip Code) |
Daniel B. Wolfe President and Chief Financial Officer 180 Degree Capital Corp. 7 N. Willow Street, Suite 4B Montclair, NJ 07042 |
(Name and address of agent for service) |
Copy to: John J. Mahon, Esq. Schulte Roth & Zabel, LLP 1152 Fifteenth Street, NW Suite 850 Washington, DC 20005 (202) 729-7477 |
2017 | 2018 | YTD Through Q2 2019 | |
NAV Change | 11.1% | 1.5% | 6.8% |
Gross Total Return of Public Company Investments | 53.5% | 19.5% | 23.9% |
Russell Microcap Index | 13.2% | (13.0%) | 14.1% |
Q2 2019 | H1 2019 | Q2 2018-Q2 2019 | Q4 2016-Q2 2019 | |
TURN Public Portfolio Gross Total Return | 9.3% | 23.9% | 0.8% | 124.9% |
TURN Public Portfolio Gross Weighted Average | 6.8% | 16.7% | (0.3%) | 40.8% |
Russell Microcap Index | 0.9% | 14.1% | (10.4%) | 12.4% |
Russell Microcap Value Index | 1.4% | 11.9% | (11.0%) | 10.1% |
Russell 2000 | 2.1% | 17.0% | (3.3%) | 19.3% |
Russell 3000 | 4.1% | 18.7% | 9.0% | 36.2% |
S&P 500 | 4.3% | 18.5% | 10.4% | 38.1% |
Dow Jones Industrial Average | 3.2% | 15.4% | 12.2% | 42.7% |
• | Adesto Technologies Corporation (NASDAQ: IOTS) reported a solid Q1 2019, and its full year outlook was viewed favorably. For the quarter, IOTS advanced 34.7% versus 5% for the Philadelphia Semiconductor Index and increased our NAV by $0.07. |
• | TheStreet, Inc. (NASDAQ: TST) has been a highly successful investment for our shareholders and our participation is now over. In conjunction with assisting the company in retiring its preferred stock at a significant discount, we joined TST’s Board of Directors in November 2017. In the first half of 2018, TST sold its deposit and loan data collection subsidiary, RateWatch, to S&P Global for $33.5 million. TST then sold the rest of its institutional businesses, BoardEx and The Deal, to Euromoney Institutional Investor for approximately $87.3 million. On April 22, 2019, TST distributed $1.77 per share to its shareholders. As a result of that, we booked approximately $319,000 in Q2 2019 of carried interest for the TST SPV that we have managed since November of 2017. On June 9, 2019, the Board of TST voted to sell its remaining consumer business to MVEN. The deal was announced on June 12, 2019, and closed on August 7, 2019. TST is a signature investment for how we define constructive activism. In its entirety and over the life of the investment, TST generated a total realized gain of approximately $7.2 million on an investment of approximately $5 million an an IRR of 75% in a little over two years. Success! On the date of close, we resigned from the Board of TST. |
• | Iteris Inc. (NASDAQ: ITI) was a previously undisclosed position that we added to in this quarter. ITI is a provider of systems and sensors that optimize the flow of traffic and enhance driver safety. ITI announced an acquisition of a Florida based traffic management company while reporting better than expected results. The stock was up 24% in the quarter and increased our NAV by $0.02 |
• | Airgain, Inc. (NASDAQ: AIRG) benefited during the quarter from increased excitement regarding the rollout of 5G wireless technology even though its Q1 2019 earnings report missed estimates and guidance for Q2 2019 was revised lower. AIRG’s stock was up 10.3% in the quarter and increased our NAV by $0.01. |
• | Mersana Therapeutics, Inc. (NASDAQ: MRSN) continues to struggle with doing anything that the market perceives as useful in building its business. While MRSN reported data at the ASCO conference in June 2019, there was nothing of note that got investors excited. Further, its CFO resigned during the quarter. The company is currently trading with almost no enterprise value, but it burns cash every day. Following its capital raise in the first quarter of 2019, MRSN states it has enough cash to fund operations through at least mid 2021. For the quarter, MRSN decreased by 23% and decreased our NAV by $0.01. |
• | Emcore Corporation (NASDAQ: EMKR) reported Q1 2019 below expectations and subsequently reduced Q2 2019 guidance due to a Huawei sale ban. It announced the acquisition of Systron Donner, a navigation product supplier, on June 10, 2019. The company also announced results of an arbitration case that resulted in unexpected $5 million payment Phoenix Navigation Components. EMKR then pre-announced lower revenues for Q2 2019. Other than that, Mrs. Lincoln, how was the play? As we have stated numerous times in the past, EMKR is in desperate need of an overhaul of its investor relations functions. EMKR just announced the hire of a new CFO (finally after a nine-month search), so perhaps that is a start. At the very least, hopefully it will facilitate an overhaul of the company’s finance functions that do not seem to be able to accurately forecast revenues within weeks of a quarter end. The Board and management team have done a very poor job of creating value. For the quarter, EMKR decreased by 9.9%, and decreased our NAV by $0.01. |
• | Synacor, Inc. (NASDAQ: SYNC) is a holding we have discussed extensively in our previous communications with shareholders. The big news for us this year was our appointment to SYNC’s Board of Directors in March 2019. SYNC reported a decent Q1 2019, but as of the end of Q2 2019, the AT&T overhang still existed. Post the quarter end, SYNC announced the wind-down of the AT&T portal so it could more focus on the growth of the software business. Now, approximately one-half of SYNC's revenues are recurring and fee-based from its email and Cloud ID businesses. Investors typically pay a minimum of 1x recurring revenues, and in many cases, significantly higher multiples if such revenues are coupled with high margins and growth rates. The company now separately reports both revenue and profitability for its advertising and software businesses. This transparency gives investors an inside look at the financial performance of SYNC’s high margin recurring software business, and perhaps, will convince investors that SYNC’s $45 million enterprise value as of June 30, 2019, grossly undervalues the company. We look forward to helping the company engineer a "180 Degree TURN" in its share price. For the quarter, SYNC was down 0.6% and decreased our NAV by less than $0.001. |
• | Intermolecular, Inc. (NASDAQ: IMI) provides customers with a platform and multi-disciplinary development team for the research and development of advanced materials in the semiconductor, display, and glass and coatings industries. Coincident with the downturn of the semiconductor sector, in Q4 2018, we purchased approximately 1.4 million shares at an average cost of $0.94 per share. On May 6, 2019, IMI announced its sale to Merck KGaA for $1.20. Given the stock closed Q1 2019 at $1.15, IMI had a negligible impact on our NAV this quarter. We sold the entire position on the date of the announcement at an average sale price per share of $1.16, generating a total profit on the investment of $358,000, or $0.01 per share. The IRR on the investment was 52%. |
180 DEGREE CAPITAL CORP. CONSOLIDATED STATEMENT OF ASSETS AND LIABILITIES (UNAUDITED) |
June 30, 2019 | |||
ASSETS | |||
Investments in portfolio securities, at value: | |||
Unaffiliated privately held companies (cost: $14,490,404) | $ | 14,493,369 | |
Unaffiliated publicly traded securities (cost: $19,699,989) | 17,836,533 | ||
Non-controlled affiliated privately held companies (cost: $35,428,112) | 29,353,836 | ||
Non-controlled affiliated publicly traded securities (cost: $16,865,682) | 18,016,337 | ||
Controlled affiliated privately held companies (cost: $4,396,930) | 4,817,225 | ||
Equity method privately held company (adjusted cost basis: $245,658) | 245,658 | ||
Unaffiliated rights to payments (adjusted cost basis: $548,998) | 1,908,279 | ||
Cash | 5,871,341 | ||
Restricted cash | 46,151 | ||
Receivable from sales of securities | 775,399 | ||
Receivable from portfolio companies and managed funds | 160,746 | ||
Prepaid expenses | 158,188 | ||
Other assets | 112,069 | ||
Total assets | $ | 93,795,131 | |
LIABILITIES & NET ASSETS | |||
Payable for securities purchased | $ | 4,019,605 | |
Post-retirement plan liabilities | 1,119,993 | ||
Accounts payable and accrued liabilities | 812,958 | ||
Deferred rent | 26,796 | ||
Total liabilities | $ | 5,979,352 | |
Commitments and contingencies (Note 10) | |||
Net assets | $ | 87,815,779 | |
Net assets are comprised of: | |||
Preferred stock, $0.10 par value, 2,000,000 shares authorized; none issued | $ | 0 | |
Common stock, $0.01 par value, 45,000,000 shares authorized; 34,623,341 issued | 334,594 | ||
Additional paid in capital | 127,652,787 | ||
Total distributable loss | (35,566,077 | ) | |
Treasury stock, at cost 3,501,779 shares | (4,605,525 | ) | |
Net assets | $ | 87,815,779 | |
Shares outstanding | 31,121,562 | ||
Net asset value per outstanding share | $ | 2.82 |
180 DEGREE CAPITAL CORP. CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) |
Six Months Ended June 30, 2019 | |||
Income: | |||
Interest from: | |||
Unaffiliated companies-cash | $ | 1,585 | |
Unaffiliated companies-PIK | 14,646 | ||
Non-controlled affiliated companies-cash (Note 2) | (658,765 | ) | |
Non-controlled affiliated companies-PIK | 7,255 | ||
Cash and U.S. government securities | 28,085 | ||
Carried interest | 318,827 | ||
Sub-lease income | 124,333 | ||
Yield enhancing fee income on debt securities-non-cash | 100,660 | ||
Fee income for providing managerial assistance to portfolio companies-cash | 102,792 | ||
Fee income for providing managerial assistance to portfolio companies-non-cash | 73,999 | ||
Management fee income | 34,558 | ||
Dividend income | 365 | ||
Total income | 148,340 | ||
Operating fees and expenses: | |||
Salaries, bonus and benefits | 1,065,669 | ||
Professional | 255,784 | ||
Directors | 138,750 | ||
Rent | 113,967 | ||
Administration and operations | 150,849 | ||
Insurance | 118,033 | ||
Custody | 14,346 | ||
Other | 2,499 | ||
Total operating expenses | 1,859,897 | ||
Net investment loss before income tax expense | (1,711,557 | ) | |
Income tax expense | 1,617 | ||
Net investment loss | (1,713,174 | ) | |
Net realized (loss) gain from investments: | |||
Unaffiliated privately held companies | (16,960 | ) | |
Unaffiliated publicly traded securities | 1,356,039 | ||
Non-controlled affiliated privately held companies | (131,321 | ) | |
Non-controlled affiliated publicly traded securities | 3,657,621 | ||
Put options | 114,202 | ||
Net realized gain from investments | 4,979,581 | ||
Change in unrealized (depreciation) appreciation on investments: | |||
Unaffiliated privately held companies | (1,505,215 | ) | |
Unaffiliated publicly traded securities | 3,757,154 | ||
Non-controlled affiliated privately held companies | 1,918,018 | ||
Non-controlled affiliated publicly traded securities | (1,565,776 | ) | |
Controlled affiliated privately held companies | 21,998 | ||
Unaffiliated rights to payments | (111,004 | ) | |
Net change in unrealized appreciation on investments | 2,515,175 | ||
Net realized gain from investments and change in unrealized appreciation on investments | 7,494,756 | ||
Share of loss on equity method investment | (571 | ) | |
Net increase in net assets resulting from operations | $ | 5,781,011 |
180 DEGREE CAPITAL CORP. CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) |
Six Months Ended June 30, 2019 | |||
Cash flows used in operating activities: | |||
Net increase in net assets resulting from operations | $ | 5,781,011 | |
Adjustments to reconcile net increase in net assets resulting from operations to net cash used in operating activities: | |||
Net realized gain from investments | (4,979,581 | ) | |
Net change in unrealized appreciation on investments | (2,515,175 | ) | |
Share of loss on equity method investee | 571 | ||
Depreciation of fixed assets | 2,498 | ||
Accretion of bridge note PIK interest income | (21,901 | ) | |
Yield enhancing fee income on debt securities-non-cash | (100,660 | ) | |
Fee income for providing managerial assistance to portfolio companies-non-cash | (73,999 | ) | |
Purchase of U.S. government securities | (16,472,099 | ) | |
Maturity of U.S. government securities | 16,472,099 | ||
Put options purchased | (720,543 | ) | |
Written put options terminated in closing transactions | (662,408 | ) | |
Put options written | 467,452 | ||
Purchased put options terminated in closing transactions | 1,029,701 | ||
Purchase of unaffiliated privately held portfolio companies | (116,601 | ) | |
Purchase of unaffiliated publicly traded securities | (20,663,282 | ) | |
Purchase of non-controlled affiliated privately held portfolio companies | (574,019 | ) | |
Purchase of non-controlled affiliated publicly traded securities | (33,947 | ) | |
Distributions from non-controlled affiliated publicly traded securities | 8,345,936 | ||
Proceeds from sale of unaffiliated privately held companies | 255,000 | ||
Proceeds from sale of unaffiliated publicly traded securities | 5,317,688 | ||
Proceeds from sale of non-controlled affiliated privately held companies | 20,285 | ||
Proceeds from sale of non-controlled affiliated publicly traded securities | 3,399,722 | ||
Changes in assets and liabilities: | |||
Increase in receivable from sales of securities | (775,399 | ) | |
Decrease in interest receivable | 661,677 | ||
Increase in receivable from portfolio companies and managed funds | (54,084 | ) | |
Decrease on prepaid expenses | 101,171 | ||
Decrease in other assets | 17,735 | ||
Decrease in post-retirement plan liabilities | (20,413 | ) | |
Increase in payable for securities purchased | 3,927,234 | ||
Increase in accounts payable and accrued liabilities | 80,634 | ||
Decrease in deferred rent | (26,389 | ) | |
Net cash used in operating activities | (1,930,086 | ) | |
Cash flows from investing activities: | |||
Purchase of fixed assets | (285 | ) | |
Net cash used in investing activities | (285 | ) | |
Net decrease in cash and restricted cash | (1,930,371 | ) | |
Cash and restricted cash at beginning of the period | 7,847,863 | ||
Cash and restricted cash at end of the period | $ | 5,917,492 | |
Supplemental disclosures of cash flow information: | |||
Income taxes paid | $ | 1,617 | |
Cash | $ | 5,871,341 | |
Restricted cash | 46,151 | ||
Total cash and restricted cash shown in the consolidated statement of cash flows | $ | 5,917,492 |
180 DEGREE CAPITAL CORP. CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS |
Six Months Ended June 30, 2019 | Year Ended December 31, 2018 | ||||||
(UNAUDITED) | |||||||
Changes in net assets from operations: | |||||||
Net investment loss | $ | (1,713,174 | ) | $ | (2,386,019 | ) | |
Net realized gain (loss) | 4,979,581 | (7,693,523 | ) | ||||
Net change in unrealized appreciation on investments | 2,515,175 | 11,195,620 | |||||
Share of loss on equity method investment | (571 | ) | (124,299 | ) | |||
Net increase in net assets resulting from operations | 5,781,011 | 991,779 | |||||
Net increase in net assets | 5,781,011 | 991,779 | |||||
Net Assets: | |||||||
Beginning of the period/year | 82,034,768 | 81,042,989 | |||||
End of the period/year | $ | 87,815,779 | $ | 82,034,768 | |||
180 DEGREE CAPITAL CORP. FINANCIAL HIGHLIGHTS |
Six Months Ended June 30, 2019 | Year Ended Dec. 31, 2018 | Year Ended Dec. 31, 2017 | Year Ended Dec. 31, 2016 | Year Ended Dec. 31, 2015 | Year Ended Dec. 31, 2014 | ||||||||||||||||||
(UNAUDITED) | |||||||||||||||||||||||
Per Share Operating Performance | |||||||||||||||||||||||
Net asset value per share, beginning of the period/year | $ | 2.64 | $ | 2.60 | $ | 2.34 | $ | 2.88 | $ | 3.51 | $ | 3.93 | |||||||||||
Net investment loss* | (0.06 | ) | (0.07 | ) | (0.12 | ) | (0.15 | ) | (0.23 | ) | (0.25 | ) | |||||||||||
Net realized gain (loss) from investments* | 0.16 | (0.25 | ) | (0.38 | ) | (0.26 | ) | 0.15 | (0.16 | ) | |||||||||||||
Net change in unrealized appreciation (depreciation) on investments and options*1 | 0.08 | 0.36 | 0.80 | (0.12 | ) | (0.56 | ) | (0.02 | ) | ||||||||||||||
Share of loss on equity method investment*2 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01 | ) | 0.00 | ||||||||||||||||
Total* | 0.18 | 0.04 | 0.30 | (0.53 | ) | (0.65 | ) | (0.43 | ) | ||||||||||||||
Net (decrease) increase as a result of stock-based compensation expense*2 | 0.00 | 0.00 | (0.01 | ) | 0.01 | 0.03 | 0.03 | ||||||||||||||||
Net increase as a result of purchase of treasury stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | |||||||||||||||||
Net decrease as a result of acquisition of vested restricted stock awards related to employee withholding2 | 0.00 | 0.00 | (0.02 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | |||||||||||||
Total (decrease) increase from capital stock transactions | 0.00 | 0.00 | (0.03 | ) | 0.00 | 0.03 | 0.02 | ||||||||||||||||
Net (decrease) increase as a result of other comprehensive (loss) income*2 | 0.00 | 0.00 | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | |||||||||||||
Net increase (decrease) in net asset value | 0.18 | 0.04 | 0.26 | (0.54 | ) | (0.63 | ) | (0.42 | ) | ||||||||||||||
Net asset value per share, end of the period/year | $ | 2.82 | $ | 2.64 | $ | 2.60 | $ | 2.34 | $ | 2.88 | $ | 3.51 | |||||||||||
Stock price per share, end of the period/year | $ | 1.969 | $ | 1.75 | $ | 1.97 | $ | 1.38 | $ | 2.20 | $ | 2.95 | |||||||||||
Total return based on stock price | 12.51 | % | (11.17 | )% | 42.75 | % | (37.27 | )% | (25.42 | )% | (1.01 | )% | |||||||||||
Supplemental Data: | |||||||||||||||||||||||
Net assets, end of the period/year | $ | 87,815,779 | $ | 82,034,768 | $ | 81,042,989 | $ | 72,255,610 | $ | 88,711,671 | $ | 109,654,427 | |||||||||||
Ratio of expenses, excluding taxes, to quarterly average net assets | 2.18 | % | 3 ** | 3.62 | % | ** | 6.26 | % | ** | 7.88 | % | 8.15 | % | 7.14 | % | ||||||||
Ratio of expenses, including taxes, to quarterly average net assets | 2.18 | % | 3 ** | 3.63 | % | ** | 6.28 | % | 4 ** | 7.89 | % | 8.15 | % | 7.15 | % | ||||||||
Ratio of net investment loss to quarterly average net assets | (2.01 | )% | 3 ** | (2.82 | )% | (4.68 | )% | (5.64 | )% | (7.22 | )% | (6.70 | )% | ||||||||||
Average debt outstanding | $ | 0 | $ | 0 | $ | 0 | $ | 4,590,164 | $ | 3,780,822 | $ | 0 | |||||||||||
Average debt per share | $ | 0.00 | $ | 0.00 | $ | 0.00 | $ | 0.15 | $ | 0.12 | $ | 0.00 | |||||||||||
Portfolio turnover | 21.18 | % | 20.43 | % | 8.83 | % | *** | *** | *** | ||||||||||||||
Number of shares outstanding, end of the period/year | 31,121,562 | 31,121,562 | 31,121,562 | 30,904,209 | 30,845,754 | 31,280,843 |
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Unaffiliated Companies (2) - | |||||||||||||||
36.8% of net assets at value | |||||||||||||||
Privately Held Companies (Illiquid) - | |||||||||||||||
16.5% of net assets at value | |||||||||||||||
AutoTech Ventures Management I, LLC (3)(4)(5) | Asset Management & Custody Banks | ||||||||||||||
Venture capital investing in automotive-related companies | |||||||||||||||
LLC Interests (acquired 12/1/17) | (M) (L3) | 0 | $ | 0 | $ | 150,000 | |||||||||
D-Wave Systems, Inc. (3)(4)(6) | Technology Hardware, Storage & Peripherals | ||||||||||||||
Developing high-performance quantum computing systems | |||||||||||||||
Series 1 Class B Convertible Preferred Stock (acquired 9/30/08) | (M) (L3) | 1,144,869 | 1,002,074 | 1,791,046 | |||||||||||
Series 1 Class C Convertible Preferred Stock (acquired 9/30/08) | (M) (L3) | 450,450 | 487,804 | 719,531 | |||||||||||
Series 1 Class D Convertible Preferred Stock (acquired 9/30/08) | (M) (L3) | 855,131 | 748,473 | 1,365,951 | |||||||||||
Series 1 Class E Convertible Preferred Stock (acquired 11/24/10) | (M) (L3) | 269,280 | 248,049 | 448,688 | |||||||||||
Series 1 Class F Convertible Preferred Stock (acquired 11/24/10) | (M) (L3) | 258,721 | 238,323 | 431,094 | |||||||||||
Series 1 Class H Convertible Preferred Stock (acquired 6/27/14) | (M) (L3) | 460,866 | 909,088 | 1,044,000 | |||||||||||
Series 2 Class D Convertible Preferred Stock (acquired 9/30/08) | (M) (L3) | 678,264 | 736,019 | 1,083,431 | |||||||||||
Series 2 Class E Convertible Preferred Stock (acquired 6/1/12-3/22/13) | (M) (L3) | 513,900 | 659,493 | 896,307 | |||||||||||
Series 2 Class F Convertible Preferred Stock (acquired 6/1/12-3/22/13) | (M) (L3) | 493,747 | 633,631 | 861,157 | |||||||||||
5,662,954 | 8,641,205 | ||||||||||||||
Fleet Health Alliance, LLC (3)(4) | Health Care Technology | ||||||||||||||
Developing software for information transfer amongst healthcare providers and consumers | |||||||||||||||
Unsecured Convertible Bridge Note, 0%, (acquired 4/22/16, no maturity date) | (I) (L3) | $ | 225,000 | 225,000 | 56,250 | ||||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Unaffiliated Companies (2) - | |||||||||||||||
36.8% of net assets at value (cont.) | |||||||||||||||
Privately Held Companies (Illiquid) - | |||||||||||||||
16.5% of net assets at value (cont.) | |||||||||||||||
Magnolia Neurosciences Corporation (3)(4) | Pharmaceuticals | ||||||||||||||
Developing and commercializing novel therapeutics for treatment of neurodegeneration | |||||||||||||||
Series A Convertible Preferred Stock (acquired 8/3/18) | (I) (L3) | 862,872 | $ | 862,872 | $ | 868,405 | |||||||||
Nanosys, Inc. (3)(4) | Specialty Chemicals | ||||||||||||||
Developing inorganic nanowires and quantum dots for use in LED-backlit devices | |||||||||||||||
Series C Convertible Preferred Stock (acquired 4/10/03) | (I) (L3) | 803,428 | 1,500,000 | 896,045 | |||||||||||
Series D Convertible Preferred Stock (acquired 11/7/05) | (I) (L3) | 1,016,950 | 3,000,003 | 1,682,732 | |||||||||||
Series E Convertible Preferred Stock (acquired 8/13/10) | (I) (L3) | 433,688 | 496,573 | 773,870 | |||||||||||
4,996,576 | 3,352,647 | ||||||||||||||
NanoTerra, Inc. (3)(4) | Research & Consulting Services | ||||||||||||||
Developing surface chemistry and nano-manufacturing solutions | |||||||||||||||
Warrants for Common Stock expiring on 2/22/21 (acquired 2/22/11) | (I) (L3) | 4,462 | 69,168 | 0 | |||||||||||
Warrants for Series A-3 Preferred Stock expiring on 11/15/22 (acquired 11/15/12) | (I) (L3) | 47,508 | 35,403 | 29,853 | |||||||||||
104,571 | 29,853 | ||||||||||||||
Petra Pharma Corporation (3)(7) | Pharmaceuticals | ||||||||||||||
Developing small molecule inhibitors for treatment of cancer and metabolic diseases | |||||||||||||||
Series A Convertible Preferred Stock (acquired 12/23/15-1/8/18) | (H) (L3) | 1,894,798 | 1,894,798 | 637,979 | |||||||||||
Secured Convertible Bridge Note, 7% PIK, (acquired 8/30/18, maturing 7/31/19) | (H) (L3) | $ | 369,748 | 391,376 | 293,532 | ||||||||||
Secured Convertible Bridge Note, 7% PIK, (acquired 4/11/19, maturing 7/31/19) | (H) (L3) | $ | 116,601 | 118,412 | 88,809 | ||||||||||
2,404,586 | 1,020,320 | ||||||||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Unaffiliated Companies (2) - | |||||||||||||||
36.8% of net assets at value (cont.) | |||||||||||||||
Privately Held Companies (Illiquid) - | |||||||||||||||
16.5% of net assets at value (cont.) | |||||||||||||||
Phylagen, Inc. (3) | Research & Consulting Services | ||||||||||||||
Developing technology to improve human health and business productivity | |||||||||||||||
Series A Convertible Preferred Stock (acquired 11/14/18) | (M) (L3) | 548,031 | $ | 233,845 | $ | 374,689 | |||||||||
Total Unaffiliated Privately Held Companies (cost: $14,490,404) | $ | 14,493,369 | |||||||||||||
Unaffiliated Publicly Traded Securities - | |||||||||||||||
20.3% of net assets at value | |||||||||||||||
Adesto Technologies Corporation (4) | Semiconductors | ||||||||||||||
Developing low-power, high-performance solutions for the Internet of Things (IoT) | |||||||||||||||
Common Stock (acquired 10/27/15-12/31/18) | (M) (L1) | 821,371 | $ | 4,828,839 | $ | 6,694,174 | |||||||||
Airgain, Inc. (4) | Electronic Components | ||||||||||||||
Providing advanced antenna technologies for high-performance wireless communications | |||||||||||||||
Common Stock (acquired 6/4/18-2/15/19) | (M) (L1) | 100,000 | 909,545 | 1,415,000 | |||||||||||
Emcore Corporation (4) | Communications Equipment | ||||||||||||||
Providing mixed-signal optical products | |||||||||||||||
Common Stock (acquired 5/3/18-3/29/19) | (M) (L1) | 652,508 | 3,011,886 | 2,146,751 | |||||||||||
Iteris, Inc. (4) | Electronic Equipment & Instruments | ||||||||||||||
Providing applied informatics for transportation and agriculture | |||||||||||||||
Common Stock (acquired 1/18/19-6/14/19) | (M) (L1) | 409,000 | 1,779,436 | 2,114,530 | |||||||||||
Lantronix, Inc. (4) | Communications Equipment | ||||||||||||||
Providing secure data access and management solutions | |||||||||||||||
Common Stock (acquired 9/18/18-6/25/19) | (M) (L1) | 583,166 | 1,999,213 | 1,941,943 | |||||||||||
Mersana Therapeutics, Inc. (4) | Biotechnology | ||||||||||||||
Developing antibody drug conjugates for cancer therapy | |||||||||||||||
Common Stock (acquired 7/27/12-12/31/18) | (M) (L1) | 301,100 | 4,414,817 | 1,219,455 | |||||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Unaffiliated Companies (2) - | |||||||||||||||
36.8% of net assets at value (cont.) | |||||||||||||||
Unaffiliated Publicly Traded Securities - | |||||||||||||||
20.3% of net assets at value (cont.) | |||||||||||||||
OpGen, Inc. (4) | Biotechnology | ||||||||||||||
Developing tools for genomic sequence assembly and analysis | |||||||||||||||
Warrants for the Purchase of Common Stock expiring 5/8/20 (acquired 5/5/15) | (M) (L2) | 12,034 | $ | 425,579 | $ | 2,587 | |||||||||
Warrants for the Purchase of Common Stock expiring 2/17/25 (acquired 5/5/15) | (I) (L3) | 1,248 | 785 | 23 | |||||||||||
426,364 | 2,610 | ||||||||||||||
Miscellaneous Common Stocks (4)(8) | 2,329,889 | 2,302,070 | |||||||||||||
Total Unaffiliated Publicly Traded Securities (cost: $19,699,989) | $ | 17,836,533 | |||||||||||||
Total Investments in Unaffiliated Companies (cost: $34,190,393) | $ | 32,329,902 | |||||||||||||
Investments in Non-Controlled Affiliated Companies (2) - | |||||||||||||||
53.9% of net assets at value | |||||||||||||||
Privately Held Companies (Illiquid) - | |||||||||||||||
33.4% of net assets at value | |||||||||||||||
ABSMaterials, Inc. (3) | Specialty Chemicals | ||||||||||||||
Developing nano-structured absorbent materials for water remediation and consumer applications | |||||||||||||||
Series A Convertible Preferred Stock (acquired 2/17/10-10/24/11) | (I) (L3) | 390,000 | $ | 435,000 | $ | 11,595 | |||||||||
Series B Convertible Preferred Stock (acquired 11/8/13-6/25/14) | (I) (L3) | 1,037,751 | 1,217,644 | 209,332 | |||||||||||
Secured Convertible Bridge Note, 8% PIK, (acquired 1/20/16, maturing 12/31/19) | (M) (L3) | $ | 100,000 | 127,573 | 95,679 | ||||||||||
Secured Convertible Bridge Note, 8% PIK, (acquired 3/28/17, maturing 12/31/19) | (M) (L3) | $ | 25,000 | 29,521 | 22,140 | ||||||||||
1,809,738 | 338,746 | ||||||||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Non-Controlled Affiliated Companies (2) - | |||||||||||||||
53.9% of net assets at value (cont.) | |||||||||||||||
Privately Held Companies (Illiquid) - | |||||||||||||||
33.4% of net assets at value (cont.) | |||||||||||||||
AgBiome, LLC (3)(4) | Fertilizers & Agricultural Chemicals | ||||||||||||||
Providing early-stage research and discovery for agriculture and utilizing the crop microbiome to identify products that reduce risk and improve yield | |||||||||||||||
Series A-1 Convertible Preferred Units (acquired 1/30/13) | (I) (L3) | 2,000,000 | $ | 2,000,000 | $ | 11,257,908 | |||||||||
Series A-2 Convertible Preferred Units (acquired 4/9/13-10/15/13) | (I) (L3) | 417,392 | 521,740 | 2,386,632 | |||||||||||
Series B Convertible Preferred Units (acquired 8/7/15) | (I) (L3) | 160,526 | 500,006 | 1,024,449 | |||||||||||
3,021,746 | 14,668,989 | ||||||||||||||
Black Silicon Holdings, Inc. (3)(4)(9)(10) | Semiconductors | ||||||||||||||
Holding company for interest in a company that develops silicon-based optoelectronic products | |||||||||||||||
Series A Convertible Preferred Stock (acquired 8/4/15) | (M) (L3) | 233,499 | 750,000 | 0 | |||||||||||
Series A-1 Convertible Preferred Stock (acquired 8/4/15) | (M) (L3) | 2,966,667 | 890,000 | 0 | |||||||||||
Series A-2 Convertible Preferred Stock (acquired 8/4/15) | (M) (L3) | 4,207,537 | 2,445,000 | 0 | |||||||||||
Series B-1 Convertible Preferred Stock (acquired 8/4/15) | (M) (L3) | 1,892,836 | 1,169,561 | 0 | |||||||||||
Series C Convertible Preferred Stock (acquired 8/4/15) | (M) (L3) | 1,674,030 | 1,171,316 | 0 | |||||||||||
Secured Convertible Bridge Note, 8% PIK, (acquired 8/25/16, maturing 8/4/21) | (M) (L3) | $ | 1,278,453 | 1,444,368 | 576,616 | ||||||||||
7,870,245 | 576,616 | ||||||||||||||
EchoPixel, Inc. (3)(4) | Health Care Equipment | ||||||||||||||
Developing virtual reality 3-D visualization software for life sciences and health care applications | |||||||||||||||
Series Seed Convertible Preferred Stock (acquired 6/21/13-6/30/14) | (I) (L3) | 4,194,630 | 1,250,000 | 1,405,703 | |||||||||||
Series Seed-2 Convertible Preferred Stock (acquired 1/22/16) | (I) (L3) | 1,476,668 | 500,000 | 501,552 | |||||||||||
Series A-2 Convertible Preferred Stock (acquired 3/23/17) | (I) (L3) | 1,471,577 | 350,000 | 570,566 | |||||||||||
2,100,000 | 2,477,821 | ||||||||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Non-Controlled Affiliated Companies (2) - | |||||||||||||||
53.9% of net assets at value (cont.) | |||||||||||||||
Privately Held Companies (Illiquid) - | |||||||||||||||
33.4% of net assets at value (cont.) | |||||||||||||||
Essential Health Solutions, Inc. (3) | Health Care Technology | ||||||||||||||
Developing software for information transfer amongst healthcare providers and consumers | |||||||||||||||
Common Stock (acquired 11/18/16) | (I) (L3) | 200,000 | $ | 20 | $ | 135,635 | |||||||||
Series A Convertible Preferred Stock (acquired 11/18/16) | (I) (L3) | 2,750,000 | 2,750,000 | 2,943,741 | |||||||||||
Unsecured Convertible Bridge Note, 8% PIK, (acquired 12/19/18, maturing 12/19/19) | (M) (L3) | $ | 50,000 | 52,126 | 52,126 | ||||||||||
2,802,146 | 3,131,502 | ||||||||||||||
Lodo Therapeutics Corporation (3) | Pharmaceuticals | ||||||||||||||
Developing and commercializing novel therapeutics derived from a metagenome-based Natural Product Discovery Platform | |||||||||||||||
Series A Convertible Preferred Stock (acquired 12/21/15-4/22/16) | (I) (L3) | 658,190 | 658,190 | 800,246 | |||||||||||
Secured Convertible Bridge Note, 6% PIK, (acquired 6/27/19, maturing 5/7/21) | (M) (L3) | $ | 474,019 | 474,331 | 474,331 | ||||||||||
1,132,521 | 1,274,577 | ||||||||||||||
NGX Bio, Inc. (3)(4)(10) | Research & Consulting Services | ||||||||||||||
Developed translational genomics solutions | |||||||||||||||
Series Seed Convertible Preferred Stock (acquired 6/6/14-1/10/16) | (I) (L3) | 666,667 | 500,002 | 15,114 | |||||||||||
Series Seed 2 Convertible Preferred Stock (acquired 8/20/15-9/30/15) | (I) (L3) | 329,989 | 499,999 | 7,481 | |||||||||||
Series Seed 3 Convertible Preferred Stock (acquired 6/26/17) | (I) (L3) | 666,001 | 686,329 | 15,099 | |||||||||||
1,686,330 | 37,694 | ||||||||||||||
ORIG3N, Inc. (3)(4) | Health Care Technology | ||||||||||||||
Developing consumer focused genetic tests | |||||||||||||||
Series 1 Convertible Preferred Stock (acquired 2/5/15-8/5/15) | (H) (L3) | 1,195,315 | 500,000 | 1,211,768 | |||||||||||
Series A Convertible Preferred Stock (acquired 11/25/15-9/7/16) | (H) (L3) | 1,364,666 | 1,500,000 | 1,413,763 | |||||||||||
Series A-2 Convertible Preferred Stock (acquired 5/11/17-2/8/18) | (H) (L3) | 176,386 | 200,002 | 188,247 | |||||||||||
2,200,002 | 2,813,778 | ||||||||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Non-Controlled Affiliated Companies (2) - | |||||||||||||||
53.9% of net assets at value (cont.) | |||||||||||||||
Privately Held Companies (Illiquid) - | |||||||||||||||
33.4% of net assets at value (cont.) | |||||||||||||||
Produced Water Absorbents, Inc. (3)(11) | Oil & Gas Equipment & Services | ||||||||||||||
Providing integrated process separation solutions to the global oil and gas industries, enabling onsite treatment of produced and flowback water | |||||||||||||||
Common Stock (acquired 4/30/16) | (M) (L3) | 50,243,350 | $ | 7,670,281 | $ | 0 | |||||||||
Warrants for Common Stock expiring upon liquidation event (acquired 4/30/16) | (M) (L3) | 450,000 | 65,250 | 0 | |||||||||||
Senior Secured Debt, 15% commencing on 4/1/16, maturing on 12/31/19 (acquired 4/1/16) | (M) (L3) | $ | 2,533,766 | 2,424,340 | 0 | ||||||||||
10,159,871 | 0 | ||||||||||||||
TARA Biosystems, Inc. (3)(4) | Life Sciences Tools & Services | ||||||||||||||
Developing human tissue models for toxicology and drug discovery applications | |||||||||||||||
Common Stock (acquired 8/20/14) | (I) (L3) | 2,000,000 | 20 | 752,518 | |||||||||||
Series A Convertible Preferred Stock (acquired 3/31/17) | (I) (L3) | 6,878,572 | 2,545,493 | 3,180,934 | |||||||||||
Series A-2 Convertible Preferred Stock (acquired 4/18/19) | (I) (L3) | 208,577 | 100,000 | 100,661 | |||||||||||
2,645,513 | 4,034,113 | ||||||||||||||
Total Non-Controlled Affiliated Privately Held Companies (cost: $35,428,112) | $ | 29,353,836 | |||||||||||||
Investments in Non-Controlled Affiliated Companies (2) - | |||||||||||||||
53.9% of net assets at value | |||||||||||||||
Non-Controlled Affiliated Publicly Traded Securities - | |||||||||||||||
20.5% of net assets at value | |||||||||||||||
Quantum Corporation (4) | Technology Hardware, Storage & Peripherals | ||||||||||||||
Providing high-density data storage and high-speed data processing solutions | |||||||||||||||
Common Stock (acquired 2/4/19-6/25/19) | (M) (L1) | 2,104,191 | $ | 5,516,172 | $ | 5,576,106 | |||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Non-Controlled Affiliated Companies (2) - | |||||||||||||||
53.9% of net assets at value (cont.) | |||||||||||||||
Non-Controlled Affiliated Publicly Traded Securities - | |||||||||||||||
20.5% of net assets at value (cont.) | |||||||||||||||
Synacor, Inc. (4)(12) | Application Software | ||||||||||||||
Providing technology development, multiplatform services and revenue partner for video, internet and communications providers, device manufacturers, and enterprises | |||||||||||||||
Common Stock (acquired 4/6/17-5/14/19) | (M) (L1) | 1,602,420 | $ | 4,349,510 | $ | 2,499,775 | |||||||||
Stock Options for Common Stock Expiring 2/28/29 (acquired 3/1/19) (3)(13) | (I) (L3) | 50,000 | 0 | 38,392 | |||||||||||
Stock Options for Common Stock Expiring 5/16/29 (acquired 5/16/19) (3)(13) | (I) (L3) | 15,000 | 0 | 11,640 | |||||||||||
4,349,510 | 2,549,807 | ||||||||||||||
TheMaven, Inc. (3)(4) | Interactive Media & Services | ||||||||||||||
Providing a shared digital publishing, advertising and distribution platform | |||||||||||||||
Series H Convertible Preferred Stock (acquired 6/27/19) | (M) (L2) | 1,320 | 2,000,000 | 2,000,000 | |||||||||||
Series I Convertible Preferred Stock (acquired 6/28/19) | (M) (L2) | 5,000 | 5,000,000 | 5,000,000 | |||||||||||
7,000,000 | 7,000,000 | ||||||||||||||
TheStreet, Inc. (4)(14) | Financial Exchanges & Data | ||||||||||||||
Providing financial news and proprietary data to consumers and businesses | |||||||||||||||
Common Stock (acquired 4/19/17-4/4/19) | (M) (L1) | 471,521 | 0 | 2,890,424 | |||||||||||
Total Non-Controlled Affiliated Publicly Traded Securities (cost: $16,865,682) | $ | 18,016,337 | |||||||||||||
Total Investments in Non-Controlled Affiliated Companies (cost: $52,293,794) | $ | 47,370,173 | |||||||||||||
180 DEGREE CAPITAL CORP. CONSOLIDATED SCHEDULE OF INVESTMENTS AS OF JUNE 30, 2019 (UNAUDITED) | |||||||||
Method of Valuation (1) | Industry | Shares/Principal | Cost | Value |
Investments in Controlled Affiliated Companies (2) - | |||||||||||||||
5.5% of net assets at value | |||||||||||||||
Privately Held Companies (Illiquid) - |